Sales & Marketing News | pharmaphorum

News

UK government rubberstamps millions of extra COVID vaccines

The UK government has placed a 114 million-dose order with Pfizer/BioNTech and Moderna – sufficient to provide two doses to every person in Britain – in a bid to future-proof against COVID-

News

China's insulin plans will hit 2022 revenues, says Novo Nord...

Novo Nordisk has said that the introduction of value-based procurement (VBP) for insulin products by the Chinese government will have an impact on its revenues next year.

News

Novartis may have found a buyer for Sandoz; report

Just a few weeks after Novartis revealed it was considering a sale of its generics business Sandoz, there are reports that a potential buyer has already come forward.

News

Pfizer gets bumper $5.3bn order from US for oral COVID drug

Already making big profits from its COVID-19 vaccine, Pfizer looks set to bolt on another big revenue stream with its oral antiviral drug Paxlovid after scoring a $5.3 billion order for the

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

AbbVie's Humira tops ICER's list of unwarranted price hikes ...

With drug pricing controls back on the legislative table in the US, the influential Institute for Clinical and Economic Review (ICER) has published its third report on "unsupported" price i

News

US signs $1bn order for GSK, Vir's COVID-19 antibody

The US has made a sizeable order for GlaxoSmithKline and Vir Biotechnology's antibody-based COVID-19 treatment sotrovimab said to be worth approximately $1 billion.

UK government rubberstamps millions of extra COVID vaccines

China's insulin plans will hit 2022 revenues, says Novo Nord...

Novartis may have found a buyer for Sandoz; report

Pfizer gets bumper $5.3bn order from US for oral COVID drug

AbbVie's Humira tops ICER's list of unwarranted price hikes ...

US signs $1bn order for GSK, Vir's COVID-19 antibody

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks